Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan

Erectile dysfunction (ED) is a prevalent form of male sexual dysfunction. Phosphodiesterase type 5 (PDE5) inhibitor is the first-line treatment for ED. Numerous well-designed and -conducted clinical trials and postmarketing studies have established the safety and efficacy of PDE5 inhibitors for the...

Full description

Bibliographic Details

Published in:	Urological Science
Main Author:	Bang-Ping Jiann
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2016-06-01
Subjects:	erectile dysfunction PDE5 inhibitor sildenafil tadalafil vardenafil
Online Access:	http://www.sciencedirect.com/science/article/pii/S187952261630029X